NRT smoking cessation aids in Canada is set to see more muted growth in retail volume sales in 2022 after the peak in 2020 when smoking rates in the country declined in the wake of the COVID-19 pandemic which increased consumer concerns about respiratory health and general wellbeing. As these fears recede in 2022, retail volume growth is expected to be more muted, perhaps as Canadians willing to consider giving up smoking have already done so. An estimated 1 in 10 Canadians smoked cigarettes reg...
The NRT Smoking Cessation Aids in Canada report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2017-2021, allowing you to identify the sectors driving growth. Forecasts to 2026 illustrate how the market is set to change.
Product coverage: NRT Gum, NRT Inhalators, NRT Lozenges, NRT Patches, Other NRT.
Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.
The NRT Smoking Cessation Aids in Canada report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2017-2021, allowing you to identify the sectors driving growth. Forecasts to 2026 illustrate how the market is set to change.
Product coverage: NRT Gum, NRT Inhalators, NRT Lozenges, NRT Patches, Other NRT.
Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.
Why buy this report?
- Get a detailed picture of the NRT Smoking Cessation Aids market;
- Pinpoint growth sectors and identify factors driving change;
- Understand the competitive environment, the market’s major players and leading brands;
- Use five-year forecasts to assess how the market is predicted to develop.
Table of Contents
NRT SMOKING CESSATION AIDS IN CANADAKEY DATA FINDINGSCONSUMER HEALTH IN CANADADISCLAIMERDEFINITIONS
2022 DEVELOPMENTS
PROSPECTS AND OPPORTUNITIES
CATEGORY INDICATORS
CATEGORY DATA
EXECUTIVE SUMMARY
MARKET INDICATORS
MARKET DATA
APPENDIX
SOURCES